Skip to main content

Hope for CJD sufferers

Drugs already licensed for the treatment of malaria and schizophrenia could be used to treat vCJD.

Written byScott Gotlieb
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

If the apparent partial recovery of Rachel Forber, the young English woman diagnosed with vCJD continues, and if mice studies reported this week are as promising as they look, there is hope for people suffering from CJD and vCJD and for public health officials still unsure how widespread vCJD contracted from eating infected beef is likely to be.

But experts caution that clinical trials — scheduled to begin this autumn — are needed to establish efficacy and that it is possible that Ms Forber was misdiagnosed.

Ms Forber received treatment with the antimalarial drug quinacrine after her father sought help from the San Francisco-based laboratory of Stanley Prusiner, who won the Nobel prize for medicine in 1997 for his explanation of the cause of diseases such as CJD and BSE. After 19 days, she seemed to be recovering some memory and movement finctions.

The mechanism of action of quinacrine remains ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays